Loading…
Reported covered position: Legislative Assistant, Office of Rep. Betty Sutton
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
BIOSECURE Act
Client: WUXI BIOLOGICS USA LLC · Firm: FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry
BIOSECURE Act
Client: WUXI BIOLOGICS USA LLC · Firm: FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
WASTEWATER ACTION ALLIANCE via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · third_quarter · Q3
Infectious disease detection.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
SPRINGER NATURE AMERICA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · third_quarter · Q3
Source: Senate LDA
| COLOR HEALTH (FKA COLOR GENOMICS) |
| 8 |
| 2021–2022 |
| VIRTA HEALTH CORP. | 8 | 2022–2024 |
| TeleTracking Technologies, Inc. | 7 | 2021–2023 |
| DELTA DENTAL PLANS ASSOCIATION | 6 | 2023–2024 |
| SCIPHER MEDICINE CORPORATION | 6 | 2023–2024 |
| OBESITY CARE ADVOCACY NETWORK (OCAN) | 5 | 2021–2022 |
| PGA TOUR, INC. | 3 | 2026 |
| SPRINGER NATURE AMERICA, INC. | 2 | 2026 |
| NOVO NORDISK, INC. | 1 | 2021 |
BIOSECURE Act
Client: WUXI BIOLOGICS USA LLC · Firm: FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry
BIOSECURE Act
Client: WUXI BIOLOGICS USA LLC · Firm: FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry
BIOSECURE Act
Client: WUXI BIOLOGICS USA LLC · Firm: FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry
BIOSECURE Act
Client: WUXI BIOLOGICS USA LLC · Firm: FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry
Prohibiting Foreign Access to American Genetic Information Act of 2024
Client: WUXI BIOLOGICS USA LLC · Firm: FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry
Prohibiting Foreign Access to American Genetic Information Act of 2024
Client: WUXI BIOLOGICS USA LLC · Firm: FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry
Prohibiting Foreign Access to American Genetic Information Act of 2024
Client: WUXI BIOLOGICS USA LLC · Firm: FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry
Prohibiting Foreign Access to American Genetic Information Act of 2024
Client: WUXI BIOLOGICS USA LLC · Firm: FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry
Prohibiting Foreign Access to American Genetic Information Act of 2024
Client: WUXI BIOLOGICS USA LLC · Firm: FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry
Prohibiting Foreign Access to American Genetic Information Act of 2024
Client: WUXI BIOLOGICS USA LLC · Firm: FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry
Lobbying related to scientific publishing and research
Lobbying related to scientific publishing and research
Lobbying related to scientific publishing and research
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PGA TOUR, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · third_quarter · Q3
Advocacy to promote the sport of professional golf and professional golfers.
Advocacy to promote the sport of professional golf and professional golfers.
Advocacy to promote the sport of professional golf and professional golfers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · third_quarter · Q3
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SPRINGER NATURE AMERICA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · third_quarter · RR
Lobbying related to scientific publishing and research
Lobbying related to scientific publishing and research
Lobbying related to scientific publishing and research
WUXI BIOLOGICS USA LLC via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · second_quarter · Q2
Lobbying related to Congressional and Administration introductions and company updates.
Lobbying related to Congressional and Administration introductions and company updates.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WASTEWATER ACTION ALLIANCE via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · second_quarter · Q2
Infectious disease detection.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
PGA TOUR, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · second_quarter · Q2
Advocacy to promote the sport of professional golf and professional golfers.
Advocacy to promote the sport of professional golf and professional golfers.
Advocacy to promote the sport of professional golf and professional golfers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · second_quarter · Q2
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PGA TOUR, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · first_quarter · RR
Advocacy to promote the sport of professional golf and professional golfers.
Advocacy to promote the sport of professional golf and professional golfers.
Advocacy to promote the sport of professional golf and professional golfers.
WASTEWATER ACTION ALLIANCE via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · first_quarter · Q1
Infectious disease detection
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WUXI BIOLOGICS USA LLC via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · first_quarter · Q1
Lobbying related to Congressional and Administration introductions and company updates.
Lobbying related to Congressional and Administration introductions and company updates.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2026 · first_quarter · Q1
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WASTEWATER ACTION ALLIANCE via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · fourth_quarter · Q4
Infectious disease detection
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WUXI BIOLOGICS USA LLC via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · fourth_quarter · Q4
Lobbying related to Congressional and Administration introductions and company updates.
Lobbying related to Congressional and Administration introductions and company updates.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · fourth_quarter · Q4
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · third_quarter · Q3
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WASTEWATER ACTION ALLIANCE via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · third_quarter · Q3
Infectious disease detection
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WUXI BIOLOGICS USA LLC via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · third_quarter · Q3
Lobbying related to Congressional and Administration introductions and company updates.
Lobbying related to Congressional and Administration introductions and company updates.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · third_quarter · Q3
Lobbying related to developing a national solution to preserve the unique model of American athletics, while modernizing the system to increase economic opportunity for all student-athletes on issues surrounding their name, image, and likeness.
Lobbying related to developing a national solution to preserve the unique model of American athletics, while modernizing the system to increase economic opportunity for all student-athletes on issues surrounding their name, image, and likeness.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WASTEWATER ACTION ALLIANCE via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · second_quarter · Q2
Infectious disease detection
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WUXI BIOLOGICS USA LLC via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · second_quarter · Q2
Lobbying related to Congressional and Administration introductions and company updates.
Lobbying related to Congressional and Administration introductions and company updates.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · second_quarter · Q2
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · second_quarter · Q2
Lobbying related to developing a national solution to preserve the unique model of American athletics, while modernizing the system to increase economic opportunity for all student-athletes on issues surrounding their name, image, and likeness.
Lobbying related to developing a national solution to preserve the unique model of American athletics, while modernizing the system to increase economic opportunity for all student-athletes on issues surrounding their name, image, and likeness.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WASTEWATER ACTION ALLIANCE via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · first_quarter · Q1
Infectious disease detection
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WUXI BIOLOGICS USA LLC via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · first_quarter · Q1
Lobbying related to Congressional and Administration introductions and company updates.
Lobbying related to Congressional and Administration introductions and company updates.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · first_quarter · 1T
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · first_quarter · Q1
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2025 · first_quarter · Q1
Lobbying related to developing a national solution to preserve the unique model of American athletics, while modernizing the system to increase economic opportunity for all student-athletes on issues surrounding their name, image, and likeness.
Lobbying related to developing a national solution to preserve the unique model of American athletics, while modernizing the system to increase economic opportunity for all student-athletes on issues surrounding their name, image, and likeness.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WASTEWATER ACTION ALLIANCE via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · fourth_quarter · Q4
Infectious disease detection
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WUXI BIOLOGICS USA LLC via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · fourth_quarter · Q4
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · fourth_quarter · Q4
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · fourth_quarter · Q4
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · fourth_quarter · Q4
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WASTEWATER ACTION ALLIANCE via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · fourth_quarter · RR
Infectious disease detection
WUXI BIOLOGICS USA LLC via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · third_quarter · Q3
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CATALYST4, INC. (ON BEHALF OF WASTEWATERSCAN) via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · third_quarter · Q3
Lobbying related to monitoring disease through municipal wastewater systems to inform public health responses
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · third_quarter · Q3
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · third_quarter · Q3
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · third_quarter · Q3
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
DELTA DENTAL PLANS ASSOCIATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · second_quarter · Q2
Lobbying related to dental coverage and oral health
Lobbying related to dental coverage and oral health
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CATALYST4, INC. (ON BEHALF OF WASTEWATERSCAN) via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · second_quarter · Q2
Lobbying related to monitoring disease through municipal wastewater systems to inform public health responses
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · second_quarter · Q2
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · second_quarter · Q2
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · second_quarter · Q2
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WUXI BIOLOGICS USA LLC via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · second_quarter · Q2
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry
HR 8333, the BIOSECURE Act; S. 3558 Prohibiting Foreign Access to American Genetic Data Information Act of 2024; communications related to company operations and CRDMO industry
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
WUXI BIOLOGICS USA LLC via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · first_quarter · Q1
Lobbying related to Congressional and Administration introductions and company updates.
Lobbying related to Congressional and Administration introductions and company updates.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DELTA DENTAL PLANS ASSOCIATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · first_quarter · Q1
Lobbying related to dental coverage and oral health
Lobbying related to dental coverage and oral health
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCIPHER MEDICINE CORPORATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · first_quarter · 1T
Lobbying related to CMS coverage determination.
Lobbying related to CMS coverage determination.
CATALYST4, INC. (ON BEHALF OF WASTEWATERSCAN) via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · first_quarter · Q1
Lobbying related to monitoring disease through municipal wastewater systems to inform public health responses
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · first_quarter · Q1
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIRTA HEALTH CORP via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · first_quarter · 1T
Lobbying related to interventions for metabolic disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · first_quarter · Q1
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2024 · first_quarter · Q1
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WUXI BIOLOGICS USA LLC via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · fourth_quarter · Q4
Lobbying related to Congressional and Administration introductions and company updates.
Lobbying related to Congressional and Administration introductions and company updates.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELTA DENTAL PLANS ASSOCIATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · fourth_quarter · Q4
Lobbying related to dental coverage and oral health
Lobbying related to dental coverage and oral health
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCIPHER MEDICINE CORPORATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · fourth_quarter · Q4
Lobbying related to CMS coverage determination.
Lobbying related to CMS coverage determination.
CATALYST4, INC. (ON BEHALF OF WASTEWATERSCAN) via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · fourth_quarter · Q4
Lobbying related to monitoring disease through municipal wastewater systems to inform public health responses
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · fourth_quarter · Q4
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIRTA HEALTH CORP via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · fourth_quarter · Q4
Lobbying related to interventions for metabolic disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · fourth_quarter · Q4
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · fourth_quarter · Q4
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WUXI BIOLOGICS USA LLC via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · third_quarter · Q3
Lobbying related to Congressional and Administration introductions and company updates.
Lobbying related to Congressional and Administration introductions and company updates.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DELTA DENTAL PLANS ASSOCIATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · third_quarter · Q3
Lobbying related to dental coverage and oral health
Lobbying related to dental coverage and oral health
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCIPHER MEDICINE CORPORATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · third_quarter · Q3
Lobbying related to CMS coverage determination.
Lobbying related to CMS coverage determination.
Filing targets: Health & Human Services, Dept of (HHS)
CATALYST4, INC. (ON BEHALF OF WASTEWATERSCAN) via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · third_quarter · Q3
Lobbying related to monitoring disease through municipal wastewater systems to inform public health responses
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · third_quarter · Q3
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIRTA HEALTH CORP via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · third_quarter · Q3
Lobbying related to interventions for metabolic disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · third_quarter · Q3
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · third_quarter · Q3
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WUXI BIOLOGICS USA LLC via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · third_quarter · RR
Lobbying related to Congressional and Administration introductions and company updates.
Lobbying related to Congressional and Administration introductions and company updates.
DELTA DENTAL PLANS ASSOCIATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · second_quarter · Q2
Lobbying related to dental coverage and oral health
Lobbying related to dental coverage and oral health
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCIPHER MEDICINE CORPORATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · second_quarter · Q2
Lobbying related to CMS coverage determination.
Lobbying related to CMS coverage determination.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CATALYST4, INC. (ON BEHALF OF WASTEWATERSCAN) via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · second_quarter · Q2
Lobbying related to monitoring disease through municipal wastewater systems to inform public health responses
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · second_quarter · Q2
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIRTA HEALTH CORP via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · second_quarter · Q2
Lobbying related to interventions for metabolic disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · second_quarter · Q2
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · second_quarter · Q2
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DELTA DENTAL PLANS ASSOCIATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · second_quarter · RR
Lobbying related to dental coverage and oral health
Lobbying related to dental coverage and oral health
SCIPHER MEDICINE CORPORATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · first_quarter · Q1
Lobbying related to CMS coverage determination.
Lobbying related to CMS coverage determination.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CATALYST4, INC. (ON BEHALF OF WASTEWATERSCAN) via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · first_quarter · Q1
Lobbying related to monitoring disease through municipal wastewater systems to inform public health responses
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · first_quarter · Q1
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIRTA HEALTH CORP via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · first_quarter · Q1
Lobbying related to interventions for metabolic disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
TELETRACKING TECHNOLOGIES, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · first_quarter · 1T
Lobbying related to COVID-19 data collection from hospitals.
Lobbying related to COVID-19 data collection from hospitals.
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · first_quarter · Q1
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · first_quarter · Q1
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCIPHER MEDICINE CORPORATION via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · first_quarter · RR
Lobbying related to CMS coverage determination
Lobbying related to CMS coverage determination
CATALYST4, INC. (ON BEHALF OF WASTEWATERSCAN) via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2023 · first_quarter · RR
Lobbying related to monitoring disease through municipal wastewater systems to inform public health responses.
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · fourth_quarter · Q4
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIRTA HEALTH CORP via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · fourth_quarter · Q4
Lobbying related to interventions for metabolic disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
TELETRACKING TECHNOLOGIES, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · fourth_quarter · Q4
Lobbying related to COVID-19 data collection from hospitals.
Lobbying related to COVID-19 data collection from hospitals.
Filing targets: Health & Human Services, Dept of (HHS)
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · fourth_quarter · Q4
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · fourth_quarter · Q4
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COLOR HEALTH (FKA COLOR GENOMICS) via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · fourth_quarter · 4T
Lobbying related to healthcare issues.
Lobbying related to healthcare issues.
Filing targets: Health & Human Services, Dept of (HHS)
PHREESIA, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · fourth_quarter · RR
Lobbying related to patient reported quality measurement
Lobbying related to patient reported quality measurement
VIRTA HEALTH CORP via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · third_quarter · Q3
Lobbying related to interventions for metabolic disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
TELETRACKING TECHNOLOGIES, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · third_quarter · Q3
Lobbying related to COVID-19 data collection from hospitals.
Lobbying related to COVID-19 data collection from hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KALDEROS, INC. via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · third_quarter · Q3
Lobbying related to the 340B drug discount program
Lobbying related to the 340B drug discount program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL FOR SPECIAL SURGERY via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · third_quarter · Q3
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Lobbying related to securing funding from the CARES and Paycheck Protection and Health Care Enhancement Acts as well as future economic stimulus legislation and tele-physical therapy.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COLOR HEALTH (FKA COLOR GENOMICS) via FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)
2022 · third_quarter · Q3
Lobbying related to healthcare issues.
Lobbying related to healthcare issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office